MIRA INFORM REPORT

 

 

Report Date :

14.06.2007

 

IDENTIFICATION DETAILS

 

Name :

ALKALOIDS CORPORATION

 

 

Registered Office :

8, Bentinck Street, Kolkata – 700 001, West Bengal

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

1967

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CALA00242E

 

 

Legal Form :

Partnership concern with an unlimited liability of the partners.

 

 

Line of Business :

Manufacturers and Exporters of Phytochemicals, Herbal extracts and

 Nutraceuticals.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 20000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed concern having satisfactory track.  Partners are reported as experienced and respectable businessmen.  Trade relations are reported as fair.  Business is active.  Payments are usually correct and as per commitments.

 

The concern can be considered normal for business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

8, Bentinck Street, Kolkata (Calcutta) – 700 001, West Bengal, India

Tel. No.:

91-33-22435841 / 22485464 / 22481263

Fax No.:

91-33-22488449

E-Mail :

alkacorp@vsnl.com

Website :

http://www.alkaloidscorp.com

Area :

1000 Sq. fts.

Location :

Rented

 

 

PARTNERS

 

Name :

Mr. R K Karnani

Designation :

Partner

 

 

Name :

Mr. M L Karnani

Designation :

Partner

 

 

Name :

Mr. S L Karnani

Designation :

Partner

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers and Exporters of Phytochemicals, Herbal extracts and Nutraceuticals.

 

 

Products :

Phytochemicals

  • Andrographolide
  • Artemether Int. Ph.
  • Artesunate Int. Ph.
  • Camptothecin 98%
  • Cimetropium Bromide
  • Colchicine BP/USP
  • 10-Deacetylbaccatin-III (10-DAB)
  • Digoxin USP
  • Forskolin
  • Hyoscine Butylbromide BP
  • Lysergol
  • Methoxsalen USP
  • Papaverine Hydrochloride BP
  • Podophyllum Resin BP
  • Reserpine BP/USP
  • Scopine Hydrochloride
  • Scopolamine Hydrobromide USP
  • Scopolamine Methylbromide USP
  • Scopolamine Methylnitrate
  • Thiocolchicoside FP
  • Yohimbine Hydrochloride USP

Standardized Herbal Extracts

  • Coleus Forskohli Extract
  • Green Tea Extract
  • Horse chestnut Extract
  • Ipecac Soft Extract
  • Yohimbe Extract

They are shortly introducing:

  • Aescin
  • Arecoline Hydrobromide

 

 

Exports :

 

Products :

v      Phytochemicals

v      Herbal Extracts

v      Nutraceuticals

Countries :

Europe, USA, Japan

 

 

Imports :

 

Products :

Raw Materials

Countries :

Europe

 

 

Terms :

 

Selling :

L/C, Credit

 

 

Purchasing :

L/C, Credit (30 days)

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and End Users

 

 

No. of Employees :

12

 

 

Bankers :

Citi Bank N A

Kolkata, West Bengal, India

 

 

Facilities :

The concern enjoys some facilities from its banker.

 

 

Satisfactory

Banking Relations :

 

 

 

Associates/Subsidiaries :

Alkaloids Private Limited

Kolkata, West Bengal, India

 

 

CAPITAL STRUCTURE

 

 

Capital Investment :

(Estimated)

Owned :

Rs. 5.000

Borrowed :

-

Total :

Rs. 5.000

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

Particulars

 

 

 

31.03.2007

Sales Turnover

 

 

400.000

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Website details attached:

 

Profile

 

Subject is a family concern. They started their activity at Calcutta in 1967, initially with the production of natural Caffeine from Tea. Over the years a number of Speciality products they’re included in their Product portfolio.

They have always laid strong emphasis on quality, delivery schedule and proper customer feedback. Use of modern equipments under strict hygienic conditions encompasses each and every phase of processing.

Continual investment in Production and Quality Control facilities enables us to offer high quality products within the stipulated time frame.

Their company has developed wide contacts and has established strong relationship with raw material suppliers. They are guaranteed of regular supply of Good Quality raw materials. They have also encouraged farmers to take up cultivation of medicinal plants to counter over-exploitation and depletion of certain plant species

 

The company has undergone phenomenal growth during the last few years. This has resulted in the Government of India awarding us "EXPORT HOUSE" status.


Following countries have reposed confidence in their products:


Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, China, Croatia, Czech Republic, Denmark, Egypt, France, Germany, Hong Kong, Indonesia, Japan, Korea, Malaysia, Mexico, Nepal, Portugal, Singapore, Slovak Republic, South Africa, Spain, Sri Lanka, Switzerland, Taiwan, The Netherlands, Turkey, U.K., U.S.A, Venezuela... and the number is growing

 

Manufacturing

 

Subject has been in the Phytochemicals manufacturing business ever since its inception. They are one of the leading manufacturers of Phytochemicals in India and are internationally considered as a reliable supplier of high quality Phytochemicals for use as Active Pharmaceutical Ingredients (API) / intermediates. Their manufacturing facilities are located near Hyderabad and Pune.

Manufacturing activity is carried out strictly as per WHO cGMP guidelines and several conventional and modern techniques are used for the isolation and purification of Phytochemicals. Many of their products are distributed by leading Analytical Reagent companies.

The rich experience of their people in the field of Natural Products and their innovative approach has been their strength.


They also take up bulk production of newly discovered molecules for their valued customers on an exclusive basis.

 

They lay special emphasis on:

 

v      Using dedicated equipment to avoid cross-contamination

v      Validation of equipment & critical processing steps.

v      Training of personnel

v      Self-Inspection

 

Herbal Extracts and Nutraceuticals

 

Their Herbal Extracts manufacturing facility houses a Falling Film Evaporator (FFE) and Spray Dryer apart from the normal machinery required for extraction of Crude Drugs.

Extraction is carried out with adequate care and strictly as per the requirement of a particular product. Extracts are concentrated at low temperatures, ensuring that the active ingredients retain their character and undesired artifacts are not formed.

Drying of Extracts is carried out in Spray/Vacuum Dryers under hygienic conditions.

In order to meet the growing demand for Nutraceuticals in developed countries, they have set up a state of the art Nutraceuticals manufacturing facility recently.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 40.84

UK Pound

1

Rs. 80.47

Euro

1

Rs. 54.32

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions